Genetics Tests : How to Improve Management Within Two Medical Specialities
ORGAGENE
1 other identifier
observational
36
1 country
1
Brief Summary
This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 18, 2017
CompletedFirst Submitted
Initial submission to the registry
June 18, 2018
CompletedFirst Posted
Study publicly available on registry
June 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2022
CompletedApril 19, 2023
April 1, 2023
4.6 years
June 18, 2018
April 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Characteristics of the determining factors
Characteristics of the determining factors (medical, sociological, ethical and legal) in the medical practices during the implementation of an ECGP
through study completion, an average of 1 year
Study Arms (2)
Doctors
Patients
Interventions
Eligibility Criteria
genetics tests
You may qualify if:
- Specialists in Oncology, Endocrinology, Neurology and Medical Genetics
- Doctors who have already received and returned genetics tests results
- Main hospital exercise (CHU, CH, CRLCC) on the territory of the HUGO interregion regrouping the administrative regions Bretagne, Pays-de-Loire and Centre
- Adults who having benefited genetics tests
- Ability to express oneself easily in French and whose clinical situation allows it
You may not qualify if:
- liberal doctor
- Patient refusing to participated in the study
- Medical contraindication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rennes University Hospitallead
- IMT Atlantique Nantes - Francecollaborator
- Université de Caen Normandiecollaborator
- Université Rennes 1 - Francecollaborator
Study Sites (1)
CHU de Rennes
Rennes, 35 033, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Laurent Pasquier, MD
Rennes University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2018
First Posted
June 28, 2018
Study Start
September 18, 2017
Primary Completion
April 13, 2022
Study Completion
April 13, 2022
Last Updated
April 19, 2023
Record last verified: 2023-04